International Journal of Clinical Case Reports 2024, Vol.14, No.3, 117-129 http://medscipublisher.com/index.php/ijccr 126 Chen J., Chen J., and Xu Q., 2022, Current developments and challenges of mRNA vaccines., Annual Review of Biomedical Engineering, 24: 85-109. https://doi.org/10.1146/annurev-bioeng-110220-031722 PMid:35231177 Chu L., McPhee R., Huang W., Bennett H., Pajon R., Nestorova B., and Leav B., 2021, A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine, Vaccine, 39: 2791-2799. https://doi.org/10.1016/j.vaccine.2021.02.007 PMid:33707061 PMCid:PMC7871769 Fan Y., Chan K., and Hung I., 2021, Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of different vaccines at phase 3, Vaccines, 9(9): 989. https://doi.org/10.3390/vaccines9090989. PMid:34579226 PMCid:PMC8473448 Feldman R., Fuhr R., Smolenov I., Ribeiro A., Panther L., Watson M., Senn J., Smith M., Almarsson Ӧ., Pujar H., Laska M., Thompson J., Zaks T., and Ciaramella G., 2019, mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials, Vaccine, 37: 3326-3334. https://doi.org/10.1016/j.vaccine.2019.04.074 PMid:31079849 Gote V., Bolla P., Kommineni N., Butreddy A., Nukala P., Palakurthi S., and Khan W., 2023, A comprehensive review of mRNA vaccines, International Journal of Molecular Sciences, 24(3): 2700. https://doi.org/10.3390/ijms24032700 PMid:36769023 PMCid:PMC9917162 Graña C., Ghosn L., Evrenoglou T., Jarde A., Minozzi S., Bergman H., Buckley B., Probyn K., Villanueva G., Henschke N., Bonnet H., Assi R., Menon S., Marti M., Devane D., Mallon P., Lelièvre J., Askie L., Kredo T., Ferrand G., Davidson M., Riveros C., Tovey D., Meerpohl J., Grasselli G., Rada G., Hrõbjartsson A., Ravaud P., Chaimani A., and Boutron I., 2022, Efficacy and safety of COVID‐19 vaccines, The Cochrane Database of Systematic Reviews, 12(12): CD015477. https://doi.org/10.1002/14651858.CD015477 PMid:36473651 PMCid:PMC9726273 Iavarone C., O'hagan D., Yu D., Delahaye N., and Ulmer J., 2017, Mechanism of action of mRNA-based vaccines, Expert Review of Vaccines, 16: 871-881. https://doi.org/10.1080/14760584.2017.1355245 PMid:28701102 Ioannou G., Bohnert A., O'Hare A., Boyko E., Maciejewski M., Smith V., Bowling C., Viglianti E., Iwashyna T., Hynes D., Berry K., Green P., Fox A., Korpak A., Shahoumian T., Hickok A., Rowneki M., Wang X., and Locke E., 2022, Effectiveness of mRNA COVID-19 vaccine boosters against infection, hospitalization, and death: a target trial emulation in the omicron (B.1.1.529) variant era, Annals of Internal Medicine, 175(12): 1693-1706. https://doi.org/10.7326/M22-1856 PMid:36215715 PMCid:PMC9575390 Jackson N., Kester K., Casimiro D., Gurunathan S., and Derosa F., 2020, The promise of mRNA vaccines: a biotech and industrial perspective, NPJ Vaccines, 5: 11. https://doi.org/10.1038/s41541-020-0159-8 PMid:32047656 PMCid:PMC7000814 Kim J., Eygeris Y., Gupta M., and Sahay G., 2021, Self-assembled mRNA vaccines, Advanced Drug Delivery Reviews, 170: 83-112. https://doi.org/10.1016/j.addr.2020.12.014 PMid:33400957 PMCid:PMC7837307 Klein N., Stockwell M., Demarco M., Gaglani M., Kharbanda A., Irving S., Rao S., Grannis S., Dascomb K., Murthy K., Rowley E., Dalton A., DeSilva M., Dixon B., Natarajan K., Stenehjem E., Naleway A., Lewis N., Ong T., Patel P., Konatham D., Embí P., Reese S., Han J., Grisel N., Goddard K., Barron M., Dickerson M., Liao I., Fadel W., Yang D., Arndorfer J., Fireman B., Griggs E., Valvi N., Hallowell C., Zerbo O., Reynolds S., Ferdinands J., Wondimu M., Williams J., Bozio C., Link-Gelles R., Azziz‐Baumgartner E., Schrag S., Thompson M., and Verani J., 2022, Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5-17 Years - VISION Network, 10 states, April 2021-January 2022, Morbidity and Mortality Weekly Report, 71: 352-358. https://doi.org/10.15585/mmwr.mm7109e3 PMid:35239634 PMCid:pmc8893336 Knezevic I., Liu M., Peden K., Zhou T., and Kang H., 2021, Development of mRNA vaccines: scientific and regulatory issues, Vaccines, 9(2): 81. https://doi.org/10.3390/vaccines9020081 PMid:33498787 PMCid:PMC7910833 Korang S., Rohden E., Veroniki A., Ong G., Ngalamika O., Siddiqui F., Juul S., Nielsen E., Feinberg J., Petersen J., Legart C., Kokogho A., Maagaard M., Klingenberg S., Thabane L., Bardach A., Ciapponi A., Thomsen A., Jakobsen J., and Gluud C., 2022, Vaccines to prevent COVID-19: A living systematic review with trial sequential analysis and network meta-analysis of randomized clinical trials, PLoS ONE, 39(17): 3845-3852. https://doi.org/10.1371/journal.pone.0260733 PMid:35061702 PMCid:PMC8782520
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==